Dogwood Therapeutics, Inc. (DWTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$3.90M2021: -$15.69M2022: -$11.47M2023: -$4.87M2024: -$8.79M2025: -$15.62M-$15.62M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$15.62M-77.7%
2024-$8.79M-80.5%
2023-$4.87M+57.5%
2022-$11.47M+26.9%
2021-$15.69M-302.8%
2020-$3.90M